Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Aug 1;176(2):407-13.
doi: 10.1084/jem.176.2.407.

Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation

Affiliations

Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation

X Sheng-Tanner et al. J Exp Med. .

Abstract

Intravenous infusion of mice with major histocompatibility complex (MHC) incompatible lymphocytes can inhibit the response of recipient T cells capable of recognizing the injected cells, and can enhance survival of grafts sharing MHC with the injected cells. However, neither T cell inactivation nor graft survival enhancement is always achieved. This is particularly true for donor cells that are fully allogeneic (as compared to semiallogeneic) to the recipient. We show here that both donor-specific induced response reduction and graft survival enhancement are directly correlated with the ability of the injected lymphoid cells to persist in the recirculating lymphocyte pool of the host. Whether donor cells persist correlates inversely with the level of natural killer cell (NK) activity in the host. Fully allogeneic cells can only persist in hosts with low NK activity and can then induce response reduction. Both persistence and response reduction are abrogated by injection of the host with poly-I:C, a treatment that boosts host NK activity. The same treatment also destroys the ability of semiallogeneic injected cells to persist, to induce response reduction, and to enhance skin graft survival.

PubMed Disclaimer

References

    1. Transplant Proc. 1976 Jun;8(2):147-56 - PubMed
    1. J Immunol. 1986 Oct 1;137(7):2080-8 - PubMed
    1. J Immunol. 1977 Jun;118(6):2130-7 - PubMed
    1. J Exp Med. 1991 Sep 1;174(3):571-81 - PubMed
    1. N Engl J Med. 1991 Oct 24;325(17):1210-3 - PubMed

Publication types